<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND AND PURPOSE: <z:e sem="disease" ids="C0752143" disease_type="Disease or Syndrome" abbrv="">Intracranial thrombus</z:e> is a principal feature in most <z:hpo ids='HP_0002140'>ischemic stroke</z:hpo>, and <z:e sem="disease" ids="C0302148,C0087086" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">thrombus</z:e> location and size may correlate with outcome and response to thrombolytic therapy </plain></SENT>
<SENT sid="1" pm="."><plain>EP-2104R is a fibrin-specific molecular <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MR</z:e> agent that has previously been shown to enhance extracranial and venous sinus <z:e sem="disease" ids="C0087086" disease_type="Disease or Syndrome" abbrv="">thrombi</z:e> in animal models and, recently, in clinical trials </plain></SENT>
<SENT sid="2" pm="."><plain>In this study, we examined whether this fibrin-specific <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MR</z:e> probe could noninvasively characterize intracranial arterial <z:e sem="disease" ids="C0087086" disease_type="Disease or Syndrome" abbrv="">thrombi</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>METHODS: Embolic <z:hpo ids='HP_0001297'>stroke</z:hpo> was induced in adult rats by occlusion of the right internal carotid artery with an aged <z:e sem="disease" ids="C0302148,C0087086" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">thrombus</z:e> </plain></SENT>
<SENT sid="4" pm="."><plain>We used diffusion-weighted imaging, time of flight angiography, and high-resolution 3-dimensional T1-weighted MRI at 4.7 T before and after use of contrast agents EP-2104R (n=6) and <z:chebi fb="0" ids="31797">gadopentetate dimeglumine</z:chebi> (n=5) </plain></SENT>
<SENT sid="5" pm="."><plain>RESULTS: In <z:hpo ids='HP_0000001'>all</z:hpo> animals, <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MR</z:e> angiography revealed a flow deficit and diffusion-weighted imaging showed hyperintensity consistent with <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> </plain></SENT>
<SENT sid="6" pm="."><plain>Using EP-2104R-enhanced MRI, we saw occlusive <z:e sem="disease" ids="C0087086" disease_type="Disease or Syndrome" abbrv="">thrombi</z:e> and vessel wall enhancement in <z:hpo ids='HP_0000001'>all</z:hpo> 6 animals with high contrast to noise relative to blood, whereas <z:chebi fb="0" ids="31797">gadopentetate dimeglumine</z:chebi>-injected animals showed no occlusive <z:e sem="disease" ids="C0302148,C0087086" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">thrombus</z:e> or vessel wall enhancement </plain></SENT>
<SENT sid="7" pm="."><plain>The concentration of <z:chebi fb="0" ids="33375">gadolinium</z:chebi> in the <z:e sem="disease" ids="C0302148,C0087086" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">thrombus</z:e> after EP-2104R was 18 times that in the blood pool </plain></SENT>
<SENT sid="8" pm="."><plain>CONCLUSIONS: EP-2104R-enhanced MRI successfully identifies <z:e sem="disease" ids="C0752143" disease_type="Disease or Syndrome" abbrv="">intracranial thrombus</z:e> in a rat embolic <z:hpo ids='HP_0001297'>stroke</z:hpo> model </plain></SENT>
</text></document>